Multicentre comparison of a diagnostic assay: aquaporin-4 antibodies in neuromyelitis opticaPatrick Waters, Romain Marignier, Markus Reindl et al.|Journal of Neurology Neurosurgery & Psychiatry|2016Cited by 297
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromesEster Cantó, Manuel Comabella, Mar Tintoré et al.|Brain|2015Cited by 191
Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trialDiego Cadavid, Rogier Hintzen, Michelle Mellion et al.|The Lancet Neurology|2019Cited by 185
Update on biomarkers in neuromyelitis opticaEsther Melamed, Danielle van Pelt, Najib Kissani et al.|Neurology Neuroimmunology & Neuroinflammation|2015Cited by 119
Neurofilament ELISA validationAxel Petzold, George P. Paraskevas, Ayşe Altıntaş et al.|Journal of Immunological Methods|2009Cited by 105